Examining the Debilitating Effects of Post-COVID ParosmiaAnosmia, Coronavirus Disease 2019 (COVID-19), COVID-19 Studies, Parosmia, R&D, Smell, The LaryngoscopeAnosmia is a recognized symptom of COVID-19, with anywhere between 30% to 80% of sufferers reporting loss of smell. Read more March 29, 2022/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2022/03/Examining-the-Debilitating-Effects-of-Post-COVID-Parosmia-BioSpace-3-29-22.jpeg 350 625 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2022-03-29 13:26:132022-03-29 15:28:31Examining the Debilitating Effects of Post-COVID Parosmia